[Neuroleptic malignant syndrome]

Area of Science:

• Neuroscience
• Pharmacology
• Emergency Medicine

Background:

• Neuroleptic malignant syndrome (NMS) is a rare, life-threatening condition.
• It is characterized by hyperthermia, altered consciousness, autonomic instability, and muscle rigidity.
• NMS is an iatrogenic disorder caused by neuroleptic medications.

Purpose of the Study:

• To review the pathophysiology, frequency, course, outcome, and mortality of NMS.
• To describe the management of NMS in prehospital and emergency department settings.
• To discuss clinical features, differential diagnosis, and prevention strategies for NMS.

Main Methods:

• Literature review of NMS.
• Analysis of NMS pathophysiology, clinical presentation, and diagnostic criteria.
• Evaluation of management protocols for NMS in emergency care.

Main Results:

• NMS presents with a distinct set of symptoms including hyperthermia and rigidity.
• Early recognition and intervention are crucial for improving patient outcomes.
• Effective management strategies exist for NMS in emergency settings.

Conclusions:

• NMS requires prompt diagnosis and management to prevent severe complications and mortality.
• Understanding NMS pathophysiology and clinical features aids in timely intervention.
• Prevention through careful neuroleptic drug administration is essential.